Kalbe Farma Tbk vs Phapros Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp800 (market cap 37.45T, 41.79M 24h volume), while Phapros Tbk. trades at Rp264 (market cap 221.76B, 131.5K 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 168.9× Phapros Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (41.79M versus 131.5K). Which is the better fit depends on your goals.
| KLBF | PEHA | |
|---|---|---|
Market Cap | 37.45T | 221.76B |
Volume | 41.79M | 131.5K |
Lot | 417.89K | 1.32K |
Turnover | 33.46B | 35.27M |
Average Price | 800.79 | 268.19 |
Value | 33.46B | 35.27M |
Indicative Equilibrium Price | 800 | 264 |
Indicative Equilibrium Volume | 18.3K | 20 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →